Quotes 5-day view Delayed Nyse
2 798 280
2 106 253
1 715 433
1 736 756
2 167 053
Estimated financial data (e) (USD)
Net income 2022
Net Debt 2022
P/E ratio 2022
Net income 2023
Net Debt 2023
P/E ratio 2023
Capi. / Sales 2022
Capi. / Sales 2023
Nbr of Employees
iBio, Inc. is a developer of biopharmaceuticals and FastPharming Manufacturing System. The Company is applying its technologies to develop product candidates to treat or prevent fibrotic diseases, cancers, and infectious diseases. The Company is using its FastPharming Manufacturing System (FastPharming System) and Glycaneering Services to build a portfolio of biologic drug candidates. The Company is also using the...
All news about IBIO, INC.
09/28 IBIO : Management's Discussion and Analysis of Financial Condition and Results of Operatio..
09/27 IBIO : Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporat..
09/27 IBIO, INC. : Results of Operations and Financial Condition, Financial Statements and Exhib..
09/27 IBio, Inc. Provides Revenue Guidance for the First Half, Second Half and Full Year of F..
09/27 IBIO : Earnings Flash (IBIO) IBIO Reports Q4 Revenue $0.5M
09/27 iBio Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corpora..
09/27 Ibio, Inc. Reports Earnings Results for the Full Year Ended June 30, 2021
09/27 NORTH AMERICAN MORNING BRIEFING : Stock Futures -2-
09/20 IBIO : to Participate in the Cantor 2021 Virtual Global Healthcare Conference
09/20 iBio to Report Fiscal Fourth Quarter and Full Year 2021 Financial Results and Provide C..
09/07 iBio Announces Participation in H.C. Wainwright 23rd Annual Global Investment Conferenc..
08/31 IBIO, INC. : Change in Directors or Principal Officers (form 8-K)
08/31 Seymour Flug Resigns as Director of iBio, Inc
08/30 IBIO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
08/27 IBIO : THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF RUBRYC THERAPEUTICS, INC..
News in other languages on IBIO, INC.
Analyst Recommendations on IBIO, INC.
Technical analysis trends IBIO, INC.
Short Term Mid-Term Long Term Trends Bearish Bearish Bearish
Number of Analysts
Last Close Price
Average target price
Spread / Average Target